-
Pluristem Therapeutics Shares Hit 52-Week Low After Study Misses Endpoint
13 Jul 2022 19:06 GMT
By Chris Wack Pluristem Therapeutics Inc. shares were down 11% to $1. …
-
Mid-Afternoon Market Update: Dow Rises 150 Points; Pluristem Therapeutics Shares Spike Higher
24 Apr 2020 19:14 GMT
… Lagging Sectors
Information technology shares climbed 1.1% on … cell product candidate Remestemcel-L.
Shares of Pluristem Therapeutics Inc. (NASDAQ: PSTI) … , Inc. (NASDAQ: LLNW) shares tumbled 12% to $5.14 … reported Q1 earnings results.
Shares of Natura &Co …
-
Hematopoietic Stem Cell Transplantation (HSCT) Market Future Analysis, Geographic Overview, Shares And Trends Analysis, With Upcoming Key Players-Opportunities
28 Aug 2022 18:59 GMT
(MENAFN- Ameliorate Digital Consultancy)
The Hematopoietic Stem Cell Transplantation (HSCT) Market research report provides a 360-degree view of the market by examining political, social, monetary and industrial advancements enhancing the market growth. …
-
Pluristem Therapeutics Shares Jump on Covid-19 Study Results
10 Apr 2020 14:56 GMT
… small Israel-based biotech company. Shares of Pluristem Therapeutics (PSTI) climbed more than … for mortality survived after receiving Pluristem’s placenta-based cell-therapy … , including cardiovascular and kidney failure.
Pluristem said that four of the …
-
Pluristem says Phase 3 trial for muscle injury therapy did not meet key goal
13 Jul 2022 13:08 GMT
… Images The clinical-stage biotech Pluristem Therapeutics (NASDAQ:PSTI) said on Wednesday … to an SPPB score improvement, Pluristem will seek further regulatory advice … Yaky Yanay remarked. Read: Pluristem (PSTI) shares came under pressure in December …
-
Pluristem Posts Mixed Results From Study Of Muscle Regeneration After Hip Fracture Surgery
13 Jul 2022 14:41 GMT
Pluristem Therapeutics Inc PSTI announced topline results … muscle strength and regeneration.
Related: Pluristem's PLX-R18 Shows … walking distance.
Price Action: PSTI shares are down 7.55% at …
-
Pluristem Therapeutics Shares March Higher, Can It Continue?
11 Dec 2019 12:46 GMT
As of late, it has definitely been a great time to be an investor Pluristem Therapeutics Inc. (NASDAQ:PSTI) . The stock has moved higher by 31.7% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and …
-
Pluristem Announce the Closing of its Collaboration with Tnuva Group to Establish Cultured Food Platform
24 Feb 2022 16:39 GMT
… NEWSWIRE) -- Leading biotechnology company Pluristem Therapeutics Inc. (Nasdaq: PSTI) (TASE: … while Pluristem owns approximately 84% of NewCo's outstanding shares. Tnuva … produce dairy alternatives. About Pluristem Pluristem is pushing the boundaries of …
-
Athersys: Near-Term Progress In Stem Cell Phase 3 Trials Could Multiply Shares In 2022
20 Jan 2022 21:40 GMT
… 7% of the outstanding shares of Athersys. Healios has … to question why the shares are currently trading near … Cell Therapeutics, Mesoblast, and Pluristem Therapeutics. Source: Courtesy Stockcharts.com In … not only drive the shares higher, but also strengthen …
-
Pluristem Climbs On Collaboration With Tnuva Of Israel For Commercialization Of Alternative Meat
10 Jan 2022 15:47 GMT
Pluristem Therapeutics Inc. (PSTI) shares are trading more than 20 … meat product in 2023.
Currently, shares are at $1.80, up …